🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Monica Shokeen

Barnes-Jewish Hospital

ORCID: 0000-0001-8114-9584

Also affiliated with Washington University in St. Louis, Jewish Hospital, Alvin J. Siteman Cancer Center, Mallinckrodt (Ireland)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma”.

Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma

Molecular Imaging and Biology(2020)10.1007/s11307-020-01542-4
N/A
0.385DataRank · unranked
12 citations

Sooah Ko, Monica Shokeen, Nicholas S. Cho

Cancer-targeted pro-theranostic bi-metallic organo-coordination nanoparticles

Theranostics(2024)10.7150/thno.99863
N/A
0.360DataRank · unranked
10 citations

Lei Fang, Janaka Wansapura, Julie L. Prior, Brad Manion, Baogang Xu +9 more

Advanced quantification pipeline reveals new spatial and temporal tumor characteristics in preclinical multiple myeloma

EJNMMI Research(2025)10.1186/s13550-025-01291-x
N/A
0.104DataRank · unranked
1 citations

Jacqueline M. Godbe, Alexander Zheleznyak, Brad Manion, Junhao Hu, Julie L. Prior +4 more

Tissue biodistribution and tumor targeting of near-infrared labelled anti-CD38 antibody-drug conjugate in preclinical multiple myeloma

Oncotarget(2021)10.18632/oncotarget.28074
N/A
0DataRank · unranked
11 citations

Sooah Ko, Monica Shokeen, Nicholas S. Cho

Thrombus-targeting therapy with apyrase-annexin V fusion attenuates thrombosis without bleeding

Research Square(2021)10.21203/rs.3.rs-514573/v1
N/A
0DataRank · unranked
0 citations

Dana R. Abendschein, Soon Seog Jeong, Thomas W. Wakefield, José A. Díaz, Karla M. Bergonzi +3 more

In Vivo Quantitative Assessment of Therapeutic Response to Bortezomib Therapy in Disseminated Animal Models of Multiple Myeloma With [18F]FDG and [64Cu]LLP2A PET

Research Square(2021)10.21203/rs.3.rs-647260/v1
N/A
0DataRank · unranked
0 citations

Nikki Fettig, Francesca Fontana, John F. Dipersio, Mike Rettig, Julie O. Neal +4 more

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

Scientific Reports(2022)10.1038/s41598-021-03748-0
N/A
0DataRank · unranked
23 citations

Chantiya Chanswangphuwana, Nicholas S. Cho, Francesca Fontana, Dolonchampa Maji, Julie Ritchey +10 more

Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.019
N/A
0DataRank · unranked
1 citations

Fotis Asimakopoulos, Abdel Kareem Azab, Giada Bianchi, Manisha Bhutani, Leslie Crews +18 more

p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy

Cancer Discovery(2023)10.1158/2159-8290.cd-22-0907
N/A
0DataRank · unranked
18 citations

Xianmin Luo, Matthew Inkman, Qihao Ren, Xinming Su, Kai Ding +20 more

Development of New CD38 Targeted Peptides for Cancer Imaging

Molecular Imaging and Biology(2024)10.1007/s11307-024-01901-5
N/A
0DataRank · unranked
12 citations

Rui Tang, Kathleen Duncan, Brad Manion, Kexian Liang, Baogang Xu +8 more

Ablation of CD38 in multiple myeloma cells leads to an aggressive phenotype in a mouse xenograft model

Blood Advances(2025)10.1182/bloodadvances.2025017296
N/A
0DataRank · unranked
1 citations

Alexander Zheleznyak, Erin N. Teubner, Julie L. Prior, Brad Manion, Zhenghan Jing +10 more

Advanced Quantification Pipeline Reveals New Spatial and Temporal Tumor Characteristics in Preclinical Multiple Myeloma

Research Square(2025)10.21203/rs.3.rs-6596974/v1
N/A
0DataRank · unranked
0 citations

Jacqueline M. Godbe, Alexander Zheleznyak, Brad Manion, Junhao Hu, Julie L. Prior +4 more

Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma

European Journal of Nuclear Medicine and Molecular Imaging(2020)10.1007/s00259-020-05097-y
N/A
0DataRank · unranked
19 citations

Alexander Zheleznyak, Matt Mixdorf, Julie O’Neal, Julie Ritchey, Michael P. Rettig +4 more

Self-assembled peptide nanofibers demonstrate tunable CD38 avidity

ChemRxiv(2025)10.26434/chemrxiv-2025-5lrvw
N/A
0DataRank · unranked
0 citations

Amit Sharma, Zhenghan Jing, R. Brian Dyer, Julie L. Prior, Erin Teubner +4 more

Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma

ACS Nano(2020)10.1021/acsnano.9b09618
N/A
0DataRank · unranked
40 citations

Alexander Zheleznyak, Matthew Mixdorf, Anchal Ghai, Julie L. Prior, Kvar C. L. Black +5 more

In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PET

EJNMMI Research(2021)10.1186/s13550-021-00840-4
N/A
0DataRank · unranked
12 citations

Nikki Fettig, Francesca Fontana, John F. Dipersio, Mike Rettig, Julie O. Neal +4 more